Antagonists of MCP-1 function and methods of use thereof

The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, uses of said compounds and compositions, methods of treatment employing said compounds and compositions, and processes for preparing said compounds. Specifically, this invention relates to nov...

Full description

Saved in:
Bibliographic Details
Main Authors Laborde, Edgardo, Robinson, Louise, Meng, Fanying, Peterson, Brian, Villar, Hugo, Anuskiewicz, Steven, Ishiwata, Yoshiro, Yokochi, Shoji, Matsumoto, Yukiharu, Kakigami, Takuji, Inagaki, Hideaki, Jomori, Takahito, Matsushima, Kouji
Format Patent
LanguageEnglish
Published 22.05.2003
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, uses of said compounds and compositions, methods of treatment employing said compounds and compositions, and processes for preparing said compounds. Specifically, this invention relates to novel compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection. More specifically, the invention is related to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases.